PPS-DR Trademark

Trademark Overview

On Tuesday, June 23, 2015, a trademark application was filed for PPS-DR with the United States Patent and Trademark Office. The USPTO has given the PPS-DR trademark a serial number of 86671228. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 11, 2023. This trademark is owned by IMPRIMIS PHARMACEUTICALS, INC.. The PPS-DR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for the treatment of interstitial cystitis
pps-dr

General Information

Serial Number86671228
Word MarkPPS-DR
Filing DateTuesday, June 23, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 11, 2023
Registration Number5134795
Registration DateTuesday, January 31, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical compositions for the treatment of interstitial cystitis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 11, 2023
Primary Code005
First Use Anywhere DateWednesday, July 15, 2015
First Use In Commerce DateWednesday, July 15, 2015

Trademark Owner History

Party NameHARROW IP, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressTEMECULA, CA 92590
Party NameHARROW HEALTH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Friday, August 11, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, January 31, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 2, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 22, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 31, 2017REGISTERED-SUPPLEMENTAL REGISTER
Tuesday, December 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 27, 2016ASSIGNED TO LIE
Saturday, December 10, 2016NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, December 9, 2016APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, December 9, 2016USE AMENDMENT ACCEPTED
Friday, November 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 11, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, November 11, 2016AMENDMENT TO USE PROCESSING COMPLETE
Friday, November 11, 2016USE AMENDMENT FILED
Thursday, November 10, 2016TEAS AMENDMENT OF USE RECEIVED
Thursday, October 13, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, October 13, 2016FINAL REFUSAL E-MAILED
Thursday, October 13, 2016FINAL REFUSAL WRITTEN
Saturday, September 17, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 16, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2016NON-FINAL ACTION E-MAILED
Tuesday, April 26, 2016NON-FINAL ACTION WRITTEN
Wednesday, April 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 30, 2016ASSIGNED TO LIE
Friday, March 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 30, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2015NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2015ASSIGNED TO EXAMINER
Monday, June 29, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2015NEW APPLICATION ENTERED

Related Keywords

cystitis interstitial treatment compositions pharmaceutical